Literature DB >> 10549254

Laboratory diagnosis and monitoring of diabetes mellitus.

K Emancipator1.   

Abstract

The American Diabetes Association emphasizes fasting plasma glucose (FPG) levels, rather than the oral glucose tolerance test (OGTT), to diagnose diabetes mellitus. The diagnostic cutoff for FPG is 126 mg/dL (7.0 mmol/L). A 2-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or more during an OGTT or a random plasma glucose level of 200 mg/dL (11.1 mmol/L) or more also is diagnostic of diabetes. The 100-g, 3-hour OGTT remains the "gold standard" for gestational diabetes mellitus (GDM). Two of 4 samples exceeding cutoffs (fasting, > or = 105 mg/dL [5.8 mmol/L]; 1 hour, > or = 190 mg/dL [10.5 mmol/L]; 2 hours, > or = 165 mg/dL [9.2 mmol/L]; 3 hours, > or = 145 mg/dL [8.0 mmol/L]) indicate GDM. An effective GDM screening test is plasma glucose 1 hour after a 50-g oral glucose load. Tight control, which requires self-monitoring of blood glucose, reduces microvascular complications for patients with type 1 or type 2 diabetes. Patients with well-controlled diabetes have glycohemoglobin concentrations of 7% AIc (0.07 AIc/A) or less. Microalbuminuria indicates early, reversible, diabetic nephropathy. The random urine albumin-creatinine ratio is a convenient effective screening test. Albumin-creatinine ratios in the 0.03 to 0.30 (g/g) range indicate microalbuminuria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549254     DOI: 10.1093/ajcp/112.5.665

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Usefulness of electronic databases for the detection of unrecognized diabetic patients.

Authors:  Shlomo Vinker; Yaacov Fogelman; Asher Elhayany; Sasson Nakar; Ernesto Kahan
Journal:  Cardiovasc Diabetol       Date:  2003-11-14       Impact factor: 9.951

2.  Glycated hemoglobin A1C and diabetes mellitus in critically ill patients.

Authors:  Hai-Yan Zhang; Cai-Jun Wu; Chun-Sheng Li
Journal:  World J Emerg Med       Date:  2013
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.